DK0527813T3 - cDNA-kloner fra T-cellelymfom - Google Patents

cDNA-kloner fra T-cellelymfom

Info

Publication number
DK0527813T3
DK0527813T3 DK91908417.8T DK91908417T DK0527813T3 DK 0527813 T3 DK0527813 T3 DK 0527813T3 DK 91908417 T DK91908417 T DK 91908417T DK 0527813 T3 DK0527813 T3 DK 0527813T3
Authority
DK
Denmark
Prior art keywords
novel
expressed
proteins
cell
dna sequences
Prior art date
Application number
DK91908417.8T
Other languages
Danish (da)
English (en)
Inventor
Carol L Macleod
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of DK0527813T3 publication Critical patent/DK0527813T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK91908417.8T 1990-04-13 1991-04-12 cDNA-kloner fra T-cellelymfom DK0527813T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50968490A 1990-04-13 1990-04-13

Publications (1)

Publication Number Publication Date
DK0527813T3 true DK0527813T3 (da) 1996-12-30

Family

ID=24027673

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91908417.8T DK0527813T3 (da) 1990-04-13 1991-04-12 cDNA-kloner fra T-cellelymfom

Country Status (22)

Country Link
US (2) US5312733A (fi)
EP (1) EP0527813B1 (fi)
JP (1) JPH05506989A (fi)
KR (1) KR100212371B1 (fi)
AT (1) ATE141105T1 (fi)
AU (1) AU664535B2 (fi)
CA (1) CA2080018C (fi)
DE (1) DE69121240T2 (fi)
DK (1) DK0527813T3 (fi)
ES (1) ES2093100T3 (fi)
FI (1) FI108037B (fi)
GR (1) GR3021478T3 (fi)
HK (1) HK1006726A1 (fi)
IE (1) IE75903B1 (fi)
IL (1) IL97775A (fi)
NO (1) NO307341B1 (fi)
NZ (1) NZ237669A (fi)
PT (1) PT97355B (fi)
RU (1) RU2116346C1 (fi)
SA (1) SA92120348B1 (fi)
WO (1) WO1991016430A1 (fi)
ZA (1) ZA912489B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6784163B1 (en) * 1990-04-13 2004-08-31 Macleod Carol L. Inhibition of cationic amino acid transporter protein and uses thereof
WO1994004567A1 (en) * 1992-08-21 1994-03-03 La Jolla Cancer Research Foundation A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids
US5674704A (en) * 1993-05-07 1997-10-07 Immunex Corporation Cytokine designated 4-IBB ligand
US7211259B1 (en) 1993-05-07 2007-05-01 Immunex Corporation 4-1BB polypeptides and DNA encoding 4-1BB polypeptides
US7138500B1 (en) * 1993-05-07 2006-11-21 Immunex Corporation Antibodies to human 4-1BB
US5866329A (en) * 1995-09-27 1999-02-02 Demetriou; Achilles A. Method and probe for detection of gene associated with liver neoplastic disease
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
WO2001010908A1 (en) * 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
AU783682B2 (en) * 1999-08-04 2005-11-24 Amgen, Inc. Fhm, a novel member of the TNF ligand supergene family
WO2003027320A2 (en) * 2001-09-24 2003-04-03 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of pik3r1
EP1913401A4 (en) * 2005-08-03 2009-11-18 Astrazeneca Ab METHOD FOR IDENTIFYING AN AGENT THAT MODULATES TRANSPORTATION OF ARGININE IN A CHONDROCYTE
WO2007056854A1 (en) 2005-11-18 2007-05-24 University Health Network Method of expanding double negative t cells
KR101790647B1 (ko) 2009-06-10 2017-10-26 스티븐 사니그 리서치 인스티튜트 리미티드 표현형적 유연성을 나타내는 세포 제조 방법

Also Published As

Publication number Publication date
JPH05506989A (ja) 1993-10-14
NO923918L (no) 1992-12-01
DE69121240T2 (de) 1997-01-09
EP0527813B1 (en) 1996-08-07
DE69121240D1 (de) 1996-09-12
IE911250A1 (en) 1991-10-23
NO923918D0 (no) 1992-10-08
IL97775A (en) 1998-04-05
US5312733A (en) 1994-05-17
ES2093100T3 (es) 1996-12-16
FI108037B (fi) 2001-11-15
IL97775A0 (en) 1992-06-21
FI924575A (fi) 1992-10-09
GR3021478T3 (en) 1997-01-31
PT97355B (pt) 1998-08-31
AU7745791A (en) 1991-11-11
WO1991016430A1 (en) 1991-10-31
PT97355A (pt) 1991-12-31
CA2080018C (en) 2003-10-14
KR930700657A (ko) 1993-03-15
NO307341B1 (no) 2000-03-20
ZA912489B (en) 1992-01-29
KR100212371B1 (ko) 1999-08-02
RU2116346C1 (ru) 1998-07-27
EP0527813A1 (en) 1993-02-24
ATE141105T1 (de) 1996-08-15
HK1006726A1 (en) 1999-03-12
AU664535B2 (en) 1995-11-23
EP0527813A4 (en) 1993-05-05
CA2080018A1 (en) 1991-10-14
US5440017A (en) 1995-08-08
FI924575A0 (fi) 1992-10-09
NZ237669A (en) 1992-08-26
IE75903B1 (en) 1997-10-08
SA92120348B1 (ar) 2004-01-24

Similar Documents

Publication Publication Date Title
DK0527813T3 (da) cDNA-kloner fra T-cellelymfom
RU2346951C2 (ru) Выделенный полипептид, связывающий рецептор zalpha11-лиганда (варианты), кодирующий его полинуклеотид (варианты), вектор экспрессии (варианты) и клетка-хозяин (варианты)
DE69535375D1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
DE69130563T2 (de) Screening-verfahren für genbanken (recombinant libraries)
ATE432987T1 (de) Verfahren und zusammensetzungen zur hemmung des neoplastischen zellenwachstums
Nolan et al. Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement
Young et al. The amino acid sequences of jacalin and the Maclura pomifera agglutinin
EP0590071A4 (en) Substantially pure receptor like tgf--g(b)1 binding molecules and uses thereof
GR3019849T3 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
ATE190491T1 (de) Peptide als diagnose- und therapiemittel für spondyloarthropathien
ATE247164T1 (de) Insulinartigen wachstumsfaktor bindendes protein
ATE212056T1 (de) Methoden zur herstellung von rna viren aus cdna
DE69434118D1 (de) Klonierung und rekombinante herstellung des crf-rezeptors (crf=corticotropin ausloese faktor)
MacLeod T-cell lymphoma CDNA clones
RU2004118303A (ru) Быстросозревающие флуоресцирующие белки и способы их применения
Iqbal et al. The helical conformations of 14-and 16-residue fragments of suzukacillin, a membrane channel-forming polypeptide
Husain et al. Isolation, molecular cloning and in vitro expression of rhesus monkey (Macaca mulatta) prominin‐1. s1 complementary DNA encoding a potential hematopoietic stem cell antigen
Saito et al. Differential expression of the leucocyte
AR041564A1 (es) Genes aislados de proteinas de membrana de mamiferos reactivos relacionados
Zhang et al. Primary structure of myohemerythrin from Phascolopsis gouldii
RU97106012A (ru) Новые связывающие рка белки и их использование
EP1820859A3 (en) Methods and compositions for inhibiting neoplastic cell growth